Pharmacology

Action Mechanism of Action Reference
INHIBITOR Serum amyloid P-component inhibitor ClinicalTrials

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Amyloidosis 2 D000686 ClinicalTrials
Amyloidosis 2 D000686 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL4297966
FDA SRS 6U3F28IT58